A new trading day began on November 20, 2023, with Rallybio Corp (NASDAQ: RLYB) stock priced at $2.05, up 23.12% from the previous day of trading. During the day, the shares moved up to $2.46 and dropped to $2.00 before settling in for the closing price of $1.99. RLYB’s price has ranged from $1.96 to $9.88 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 12.04%. With a float of $16.88 million, this company’s outstanding shares have now reached $37.84 million.
The firm has a total of 41 workers. Let’s measure their productivity.
Rallybio Corp (RLYB) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rallybio Corp is 55.33%, while institutional ownership is 38.01%. The most recent insider transaction that took place on Mar 14, was worth 26,050. In this transaction an insider of this company bought 5,000 shares at a rate of $5.21, taking the stock ownership to the 5,000 shares. Before that another transaction happened on Mar 07, when Company’s Director sold 100,000 for $8.20, making the entire transaction worth $820,000. This insider now owns 2,378,969 shares in total.
Rallybio Corp (RLYB) Earnings and Forecasts
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.45 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -38.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.04% per share during the next fiscal year.
Rallybio Corp (NASDAQ: RLYB) Trading Performance Indicators
Here are Rallybio Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Rallybio Corp (RLYB)
Analysing the last 5-days average volume posted by the [Rallybio Corp, RLYB], we can find that recorded value of 0.25 million was better than the volume posted last year of 69873.0. As of the previous 9 days, the stock’s Stochastic %D was 12.09%. Additionally, its Average True Range was 0.39.
During the past 100 days, Rallybio Corp’s (RLYB) raw stochastic average was set at 11.09%, which indicates a significant decrease from 19.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.30% in the past 14 days, which was higher than the 103.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.7500, while its 200-day Moving Average is $5.4500. Now, the first resistance to watch is $2.6100. This is followed by the second major resistance level at $2.7600. The third major resistance level sits at $3.0700. If the price goes on to break the first support level at $2.1500, it is likely to go to the next support level at $1.8400. Should the price break the second support level, the third support level stands at $1.6900.
Rallybio Corp (NASDAQ: RLYB) Key Stats
With a market capitalization of 92.59 million, the company has a total of 37,794K Shares Outstanding. Currently, annual sales are 0 K while annual income is -66,650 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,370 K.